Mylan Tries Again to Quell Pricing Outrage by Offering Generic EpiPen

August 29, 2016 11:58 PM

19 0

“The weirdness of a generic drug company offering a generic version of its own branded but off-patent product is a signal that something is wrong,” he said in a statement. “In short, today’s announcement is just one more convoluted mechanism to avoid plain talk, admit to price gouging and just cut the price of EpiPen.”

While brand-name drug companies sometimes start selling so-called authorized generic versions of their own products, it is usually to undercut an outside generic competitor. In this case, Mylan faces no immediate generic threat.

Read more

To category page

Loading...